Depot tetracosactide ( DrugBank: Tetracosactide )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 83 | Addison disease | 1 |
83. Addison disease
Clinical trials : 20 / Drugs : 39 - (DrugBank : 13) / Drug target genes : 6 - Drug target pathways : 18
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01371526 (ClinicalTrials.gov) | September 2010 | 9/3/2011 | Revival of Stem Cells in Addison's Study | Revival of Autochthonous Adrenocortical Stem Cells in Autoimmune Addison's Disease | Adrenal Failure | Drug: depot tetracosactide | Newcastle University | NULL | Completed | 16 Years | 66 Years | Both | 13 | Phase 4 | United Kingdom |